Showing results (21-30 of 299) with videos related to
Sort By:
Pageof 30
Cytotherapy|August 23, 2022
Boosters for adeno-associated virus (AAV) vector (r)evolutionJoanna Szumska, Dirk GrimmFrontiers in Immunology|November 15, 2021
Adeno-Associated Viruses (AAV) and Host Immunity - A Race Between the Hare and the HedgehogKleopatra Rapti, Dirk GrimmBiotechnology Journal|January 10, 2018
Split Cas9, Not Hairs - Advancing the Therapeutic Index of CRISPR TechnologyCarolin Schmelas, Dirk GrimmMolecular Therapy : the Journal of the American Society of Gene Therapy|April 8, 2021
Best of most possible worlds: Hybrid gene therapy vectors based on parvoviruses and heterologous virusesJulia Fakhiri, Dirk GrimmMolecular Therapy : the Journal of the American Society of Gene Therapy|September 22, 2015
E Pluribus Unum: 50 Years of Research, Millions of Viruses, and One Goal--Tailored Acceleration of AAV EvolutionDirk Grimm, Sergei ZolotukhinVirus Genes|August 2, 2017
Next-generation AAV vectors for clinical use: an ever-accelerating raceJonas Weinmann, Dirk GrimmHuman Gene Therapy|August 25, 2017
Small But Increasingly Mighty: Latest Advances in AAV Vector Research, Design, and EvolutionDirk Grimm, Hildegard BüningThe Journal of Biological Chemistry|June 6, 2008
Silencing of hepatic fatty acid transporter protein 5 in vivo reverses diet-induced non-alcoholic fatty liver disease and improves hyperglycemiaHolger Doege, Dirk Grimm, Alaric Falcon, et al.Human Molecular Genetics|July 2, 2019
Next-generation AAV vectors-do not judge a virus (only) by its coverClaire Domenger, Dirk GrimmBiotechnology Journal|February 10, 2015
CRISPR genome engineering and viral gene delivery: a case of mutual attractionFlorian Schmidt, Dirk GrimmPageof 30